Table 2 |
||||
|
Endogenous basement membrane-derived angiogenesis inhibitors |
||||
|
Angiogenesis inhibitor |
Parent protein |
Domain |
Receptors |
Inhibitory activities on EC |
|
|
||||
|
Endostatin |
α1 chain of type XVIII collagen |
NC1 |
Glypicans, flk-1, α 5β1-integrin |
Proliferation, migration, tube formation, survival, tumor growth |
|
Restin |
α1 chain of type XV collagen |
NC10 |
Unknown |
Proliferation, migration, tumor growth |
|
Tumstatin |
α3 chain of type IV collagen |
NC1 |
αvβ3-integrin |
Proliferation, tube formation, survival, protein translation, tumor growth |
|
Arresten |
α1 chain of type IV collagen |
NC1 |
α1β1-integrin |
Proliferation, migration, tube formation, survival, tumor growth |
|
Canstatin |
α2 chain of type IV collagen |
NC1 |
α3β1-integrin |
Proliferation, migration, tube formation, survival, tumor growth |
|
α6(IV)NC1 |
α6 chain of type IV collagen |
NC1 |
Unknown |
Proliferation |
|
Endorepellin |
Perlecan |
Domain V |
α 2β1-integrin |
Migration, tube formation, survival, blood vessel growth in vivo |
|
|
||||
|
EC, endothelial cell. ECM, extracellular matrix. |
||||
|
Maeshima and Makino Fibrogenesis & Tissue Repair 2010 3:13 doi:10.1186/1755-1536-3-13 |
||||